Knight Therapeutics buy krebskrebs
Start price
30.11.20
/
50%
€3.50
Target price
30.11.21
€4.00
Performance (%)
5.14%
End price
01.12.21
€3.68
Summary
This prediction ended on 01.12.21 with a price of €3.68. The BUY prediction by krebskrebs finished with a performance of 5.14%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Knight Therapeutics | 1.026% | 1.026% | 5.914% | 11.932% |
| iShares Core DAX® | 0,61 % | 0,34 % | 12,06 % | 58,10 % |
| iShares Nasdaq 100 | 0,64 % | -3,17 % | 1,74 % | 84,36 % |
| iShares Nikkei 225® | -0,13 % | 8,92 % | 27,39 % | 64,84 % |
| iShares S&P 500 | 0,54 % | -0,70 % | 1,91 % | 58,67 % |
Comments by krebskrebs for this prediction
In the thread Knight Therapeutics diskutieren
In the thread Trading Knight Therapeutics
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten